Most employers have little idea what the pharmacy benefit managers they hire do with the money they exchange for the ...

Perioperative chemotherapy may be underused in patients with stage II-III esophageal cancer, according to researchers.

Five-fraction SBRT is “a robust and viable alternative” to conventionally or moderately fractionated radiotherapy for prostate cancer, researchers say.

Gilead has made the decision to withdraw the accelerated approval of Trodelvy (sacituzumab govitecan) for advanced urothelial cancer in the United States.

Updated results from the CheckMate 274 trial support the use of adjuvant nivolumab as standard care for high-risk muscle-invasive urothelial carcinoma, according to researchers.